DermTech Statistics
Total Valuation
DermTech has a market cap or net worth of $2.14 million. The enterprise value is $13.67 million.
| Market Cap | 2.14M |
| Enterprise Value | 13.67M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
DermTech has 34.96 million shares outstanding. The number of shares has increased by 13.58% in one year.
| Shares Outstanding | 34.96M |
| Shares Change (YoY) | +13.58% |
| Shares Change (QoQ) | +1.05% |
| Owned by Insiders (%) | 2.62% |
| Owned by Institutions (%) | 18.09% |
| Float | 32.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | 0.13 |
| PB Ratio | 0.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 1.34.
| Current Ratio | 3.53 |
| Quick Ratio | 3.59 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -138.80% and return on invested capital (ROIC) is -98.44%.
| Return on Equity (ROE) | -138.80% |
| Return on Assets (ROA) | -69.00% |
| Return on Capital (ROIC) | -98.44% |
| Revenue Per Employee | $75,308 |
| Profits Per Employee | -$430,904 |
| Employee Count | 208 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 11.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.15% in the last 52 weeks. The beta is 2.42, so DermTech's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -98.15% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.95 |
| Relative Strength Index (RSI) | 29.39 |
| Average Volume (20 Days) | 3,527,938 |
Short Selling Information
The latest short interest is 3.36 million, so 9.62% of the outstanding shares have been sold short.
| Short Interest | 3.36M |
| Short Previous Month | 2.85M |
| Short % of Shares Out | 9.62% |
| Short % of Float | 10.34% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, DermTech had revenue of $15.66 million and -$89.63 million in losses. Loss per share was -$2.68.
| Revenue | 15.66M |
| Gross Profit | 1.33M |
| Operating Income | -92.20M |
| Pretax Income | -89.63M |
| Net Income | -89.63M |
| EBITDA | -84.05M |
| EBIT | -89.63M |
| Loss Per Share | -$2.68 |
Balance Sheet
The company has $42.45 million in cash and $53.67 million in debt, giving a net cash position of -$11.22 million or -$0.32 per share.
| Cash & Cash Equivalents | 42.45M |
| Total Debt | 53.67M |
| Net Cash | -11.22M |
| Net Cash Per Share | -$0.32 |
| Equity (Book Value) | 39.99M |
| Book Value Per Share | 1.14 |
| Working Capital | 31.68M |
Cash Flow
In the last 12 months, operating cash flow was -$72.07 million and capital expenditures -$145,000, giving a free cash flow of -$72.22 million.
| Operating Cash Flow | -72.07M |
| Capital Expenditures | -145,000 |
| Free Cash Flow | -72.22M |
| FCF Per Share | -$2.08 |
Margins
Gross margin is 8.51%, with operating and profit margins of -588.62% and -572.19%.
| Gross Margin | 8.51% |
| Operating Margin | -588.62% |
| Pretax Margin | -572.19% |
| Profit Margin | -572.19% |
| EBITDA Margin | -536.57% |
| EBIT Margin | -572.19% |
| FCF Margin | -461.03% |
Dividends & Yields
DermTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.58% |
| Shareholder Yield | -13.58% |
| Earnings Yield | -3,662.16% |
| FCF Yield | -2,950.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2019. It was a reverse split with a ratio of 1:2.
| Last Split Date | Aug 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:2 |
Scores
DermTech has an Altman Z-Score of -8.36 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.36 |
| Piotroski F-Score | 4 |